{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:39Z","timestamp":1787004819866,"version":"build-2736575974"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jrnjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1053\/j.jrn.2019.03.083","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T18:47:56Z","timestamp":1560278876000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical Efficacy and Safety of Jinshuibao Combined With ACEI\/ARB in the Treatment of Diabetic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1053","volume":"30","author":[{"given":"Yebei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaosi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2019.03.083_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.ajkd.2011.09.017","article-title":"Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database","volume":"59","author":"Packham","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2019.03.083_bib2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.115.306825","article-title":"Epidemiology of obesity and diabetes and their cardiovascular complications","volume":"118","author":"Bhupathiraju","year":"2016","journal-title":"Circ Res"},{"key":"10.1053\/j.jrn.2019.03.083_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/BF02374501","article-title":"The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy","volume":"36","author":"Gall","year":"1993","journal-title":"Diabetologia"},{"key":"10.1053\/j.jrn.2019.03.083_bib4","first-page":"CD009403","article-title":"Vitamin B and its derivatives for diabetic kidney disease","volume":"1","author":"Raval","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jrn.2019.03.083_bib5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2019.03.083_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2019.03.083_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jep.2013.11.028","article-title":"Clinical trials of traditional Chinese medicine in the treatment of diabetic nephropathy: a systematic review based on a subgroup analysis","volume":"151","author":"Liu","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1053\/j.jrn.2019.03.083_bib8","doi-asserted-by":"crossref","first-page":"937549","DOI":"10.1155\/2013\/937549","article-title":"The effect of Chinese herbal medicine on\u00a0albuminuria levels in patients with diabetic nephropathy: a systematic review and meta-analysis","volume":"2013","author":"Xiao","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.2042-7158.2012.01601.x","article-title":"The genus Cordyceps: a chemical and pharmacological review","volume":"65","author":"Yue","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"10.1053\/j.jrn.2019.03.083_bib10","first-page":"75","article-title":"The medicinal value and clinical application of Jinshuibao capsule","volume":"7","author":"Weng","year":"2000","journal-title":"Chin J Inf Traditional Chin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3109\/0886022X.2015.1009820","article-title":"Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-converting enzyme inhibitors (ACEI)\/angiotensin receptor blockers (ARB) versus ACEI\/ARB alone in the treatment of diabetic kidney disease: a meta-analysis","volume":"37","author":"Luo","year":"2015","journal-title":"Ren Fail"},{"key":"10.1053\/j.jrn.2019.03.083_bib12","doi-asserted-by":"crossref","first-page":"6806943","DOI":"10.1155\/2018\/6806943","article-title":"Clinical efficacy of Jinshuibao capsules combined with angiotensin receptor blockers in patients with early diabetic nephropathy: a meta-analysis of randomized controlled trials","volume":"2018","author":"Lu","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib13","series-title":"Definition, diagnosis and classification of diabetes mellitus report of a WHO consulation, in Geneva World Health Organization","first-page":"442","year":"1999"},{"key":"10.1053\/j.jrn.2019.03.083_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/08860228509088195","article-title":"Microalbuminuria: an early marker of renal involvement in diabetes","volume":"9","author":"Mogensen","year":"1985","journal-title":"Uremia Invest"},{"key":"10.1053\/j.jrn.2019.03.083_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.jrn.2019.03.083_bib16","first-page":"116","article-title":"Observation on the curative effect of benazepril hydrochloride tablet combined with Jinshuibao capsule in the treatment of early diabetic nephropathy","volume":"23","author":"Guo","year":"2016","journal-title":"China Mod Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib17","first-page":"100","article-title":"Effect of Jinshuibao capsule combined with benazepril hydrochloride on early diabetic nephropathy","volume":"3","author":"Yang","year":"2011","journal-title":"J Chifeng Univ (science education)"},{"key":"10.1053\/j.jrn.2019.03.083_bib18","first-page":"450","article-title":"Effect of Jinshuibao plus benazepril on proteinuria in patients with diabetic nephropathy","volume":"15","author":"Wang","year":"2015","journal-title":"Eval Anal drug-use hospitals China"},{"key":"10.1053\/j.jrn.2019.03.083_bib19","first-page":"112","article-title":"Effect of jinshuibao combined with benazepril hydrochloride in treating diabetic nephropathy","volume":"28","author":"Li","year":"2012","journal-title":"China Foreign Med Treat"},{"key":"10.1053\/j.jrn.2019.03.083_bib20","first-page":"454","article-title":"Clinical observation on the treatment of diabetic nephropathy by Lotensin combined with Jinshuibao capsule","volume":"29","author":"Wang","year":"2011","journal-title":"J Huaihai Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib21","first-page":"2256","article-title":"Clinical study on renal protection of diabetic nephropathy patients with angiotensin-converting enzyme inhibitor combined with Jinshuibao capsule","volume":"31","author":"Cui","year":"2010","journal-title":"J Qiqihar Med Coll"},{"key":"10.1053\/j.jrn.2019.03.083_bib22","first-page":"65","article-title":"Therapeutic effect of benazepril combined with Jinshuibao on diabetic nephropathy","volume":"10","author":"Song","year":"2017","journal-title":"Chin J Clin Rational Drug Use"},{"key":"10.1053\/j.jrn.2019.03.083_bib23","first-page":"27","article-title":"Clinical observation of fosinopril combined with Jinshuibao in the treatment of early type 2 diabetic nephropathy","volume":"19","author":"Wang","year":"2007","journal-title":"Tianjin Pharm"},{"key":"10.1053\/j.jrn.2019.03.083_bib24","first-page":"890","article-title":"Effects of Jinshuibao capsule combined with perindopril on renal function in elderly patients with early diabetic nephropathy","volume":"29","author":"Huang","year":"2010","journal-title":"Herald Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib25","first-page":"96","article-title":"Clinical observation of Jinshuibao capsule combined with enalapril in the treatment of diabetic nephropathy","volume":"6","author":"Qian","year":"2012","journal-title":"Chin J Mod Drug Appl"},{"key":"10.1053\/j.jrn.2019.03.083_bib26","first-page":"180","article-title":"Curative effect of Jinshuibao capsule in treating 62 cases of early diabetic nephropathy","volume":"9","author":"Lv","year":"2014","journal-title":"China Pract Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib27","first-page":"77","article-title":"Treatment of diabetic nephropathy with Jinshuibao plus enalapril: a randomized, parallel controlled study","volume":"28","author":"Wang","year":"2014","journal-title":"J Pract Traditional Chin Intern Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib28","first-page":"938","article-title":"Clinical observation of Enalapril combined with Jinshuibao capsule in treating diabetic nephropathy","volume":"34","author":"Yang","year":"2012","journal-title":"Hebei Med J"},{"key":"10.1053\/j.jrn.2019.03.083_bib29","first-page":"64","article-title":"The efficacy of Jinshuibao capsules plus olmesartan medoxomil tablets in type 2 diabetic nephropathy","volume":"19","author":"Yu","year":"2013","journal-title":"Contemp Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib30","first-page":"759","article-title":"Clinical observation of Jinshuibao capsules combined with olmesartan medoxomil in the treatment of early type 2 diabetic nephropathy","volume":"6","author":"Cai","year":"2017","journal-title":"Clin Lab J"},{"key":"10.1053\/j.jrn.2019.03.083_bib31","first-page":"189","article-title":"A clinical analysis of 60 cases of early diabetic nephropathy treated by Jinshuibao combined with olmesartan medoxomil","volume":"12","author":"Xiang","year":"2014","journal-title":"China Health Industry"},{"key":"10.1053\/j.jrn.2019.03.083_bib32","first-page":"98","article-title":"Therapeutic effect of irbesartan combined with Jinshuibao on non-hypertensive diabetic nephropathy","volume":"49","author":"Lei","year":"2009","journal-title":"Shandong Med J"},{"key":"10.1053\/j.jrn.2019.03.083_bib33","first-page":"18","article-title":"Clinical observation on the treatment of diabetic nephropathy by irbesartan and Jinshuibao","volume":"4","author":"Wu","year":"2008","journal-title":"J Pract Diabetology"},{"key":"10.1053\/j.jrn.2019.03.083_bib34","first-page":"60","article-title":"Clinical efficacy of irbesartan combined with Jinshuibao capsule in treating senile diabetic nephropathy","volume":"36","author":"Ma","year":"2016","journal-title":"Inner Mongol J Traditional Chin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib35","first-page":"2342","article-title":"Clinical observation of irbesartan combined with Jinshuibao capsule in treating senile type 2 diabetic nephropathy","volume":"32","author":"Zhang","year":"2011","journal-title":"Jilin Med J"},{"key":"10.1053\/j.jrn.2019.03.083_bib36","first-page":"931","article-title":"Efficacy of irbesartan and Jinshuibao in treating early type 2 diabetic nephropathy","volume":"34","author":"Guo","year":"2012","journal-title":"Ningxia Med J"},{"key":"10.1053\/j.jrn.2019.03.083_bib37","first-page":"207","article-title":"Clinical observation of irbesartan and jinshuibao on diabetic nephropathy","volume":"27","author":"Ding","year":"2014","journal-title":"J Math Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib38","first-page":"2281","article-title":"Effect of Jinshuibao capsule combined with irbesartan tablets on early diabetic nephropathy and its influence on urinary albumin and oxidative stress","volume":"27","author":"Shen","year":"2018","journal-title":"Mod J Integrated Traditional Chin West Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib39","first-page":"83","article-title":"Clinical efficacy of Jinshuibao combined with irbesartan in the treatment of patients with diabetic nephropathy","volume":"29","author":"Zhang","year":"2016","journal-title":"Med Equipment"},{"key":"10.1053\/j.jrn.2019.03.083_bib40","first-page":"355","article-title":"Effect of Jinshuibao capsules combined with irbesartan treatment of patients with early diabetic nephropathy","volume":"27","author":"Xu","year":"2015","journal-title":"J Henan Med Coll"},{"key":"10.1053\/j.jrn.2019.03.083_bib41","first-page":"163","article-title":"Clinical effect observation on treatment of type 2 diabetes patients with early stage nephropathy by irbesartan and Jinshuibao together","volume":"5","author":"Zhang","year":"2017","journal-title":"Diabetes New World"},{"key":"10.1053\/j.jrn.2019.03.083_bib42","first-page":"779","article-title":"Forty cases of early type 2 diabetic nephropathy were treated by Jinshuibao capsules and candesartan cilexetil tablets","volume":"45","author":"Zhang","year":"2010","journal-title":"Zhejiang J Traditional Chin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib43","first-page":"186","article-title":"Effect of candesartan combined with Jinshuibao capsules treatment of patients with early type 2 diabetic nephropathy","volume":"9","author":"Shen","year":"2015","journal-title":"Chin J Mod Drug Appl"},{"key":"10.1053\/j.jrn.2019.03.083_bib44","first-page":"1658","article-title":"Effect of candesartan combined with Jinshuibao capsule treatment of patients with early diabetic nephropathy","volume":"25","author":"Xiu","year":"2016","journal-title":"Henan Med Res"},{"key":"10.1053\/j.jrn.2019.03.083_bib45","first-page":"5003","article-title":"Clinical observation of candesartan and Jinshuibao capsule in the treatment of early diabetic nephropathy","volume":"2","author":"Fan","year":"2015","journal-title":"J Clin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib46","first-page":"241","article-title":"Clinical observation of candesartan cilexetil tablet combined with Jinshuibao for treatment of type 2 diabetic nephropathy","volume":"30","author":"Zhang","year":"2014","journal-title":"J Guangdong Pharm Univ"},{"key":"10.1053\/j.jrn.2019.03.083_bib47","first-page":"43","article-title":"Effect of candesartan tablets combined with Jinshuibao in the treatment of early type 2 diabetic nephropathy","volume":"37","author":"Wang","year":"2018","journal-title":"Inner Mongolia J Traditional Chin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib48","first-page":"65","article-title":"Clinical observation of Jinshuibao capsules combined with losartan for treatment of early diabetic nephropathy","volume":"22","author":"Yang","year":"2013","journal-title":"Mod J Integrated Traditional Chin West Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib49","first-page":"84","article-title":"Effect of Jinshuibao capsule combined with losartan potassiumon treatment of patients with early diabetic nephropathy","volume":"18","author":"Zhong","year":"2014","journal-title":"J Clin Med Pract"},{"key":"10.1053\/j.jrn.2019.03.083_bib50","first-page":"144","article-title":"Study on the effect of Jinshuibao capsule combined with losartan potassium tablets in treating the early diabetic nephropathy","volume":"13","author":"Sun","year":"2010","journal-title":"Chin Med Mod Distance Education China"},{"key":"10.1053\/j.jrn.2019.03.083_bib51","first-page":"21","article-title":"Clinical observation of losartan potassium with Jinshuibao capsule in patients with early type 2 diabetic nephropathy","volume":"42","author":"Zhou","year":"2012","journal-title":"Xinjiang Med J"},{"key":"10.1053\/j.jrn.2019.03.083_bib52","first-page":"102","article-title":"Clinical observation of 76 cases of early type 2 diabetic nephropathy treated by the combination of potassium losartan and Jinshuibao capsule","volume":"16","author":"Gao","year":"2018","journal-title":"Guide China Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib53","first-page":"40","article-title":"Effect of telmisartan combined with Jinshuibao capsules treatment of patients with diabetic nephropathy","volume":"14","author":"Pan","year":"2016","journal-title":"Chin J Geriatr Care"},{"key":"10.1053\/j.jrn.2019.03.083_bib54","first-page":"1573","article-title":"Effections of telmisartan and Jinshuibao capsule on patients with type 2 diabetic kidney disease","volume":"30","author":"Liu","year":"2010","journal-title":"Chin Hosp Pharm J"},{"key":"10.1053\/j.jrn.2019.03.083_bib55","first-page":"2627","article-title":"Effect of paecilomyces hepiall chen on serum inflammatory factors, oxidative stress and renal function in patients with diabetic nephropathy","volume":"23","author":"Zhang","year":"2017","journal-title":"J Hainan Med Univ"},{"key":"10.1053\/j.jrn.2019.03.083_bib56","first-page":"2549","article-title":"Effects of Jinshuibao capsules and valsartan on inflammatory factors, blood pressure and renal function in patients with type 2 diabetic nephropathy","volume":"26","author":"Zhu","year":"2017","journal-title":"Mod J Integrated Traditional Chin West Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib57","first-page":"3202","article-title":"Ninety-Two cases of diabetic nephropathy treated with Jinshuibao capsule in combination with valsartan","volume":"35","author":"Zeng","year":"2015","journal-title":"Henan Traditional Chin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib58","first-page":"62","article-title":"Clinical evaluation of Jinshuibao capsules combined with valsartan for treating early diabetic nephropathy with micro-inflammation in 43 cases","volume":"26","author":"Feng","year":"2017","journal-title":"China Pharmaceuticals"},{"key":"10.1053\/j.jrn.2019.03.083_bib59","first-page":"1303","article-title":"Efficacy of Jinshuibao combined with valsartan in the treatment of early type 2 diabetic nephropathy","volume":"16","author":"Cao","year":"2007","journal-title":"Chin J New Drugs"},{"key":"10.1053\/j.jrn.2019.03.083_bib60","first-page":"206","article-title":"Clinical evaluation of valsartan plus Jinshuibao capsule in treating diabetic nephropathy","volume":"13","author":"Yan","year":"2015","journal-title":"Contemp Med Forum"},{"key":"10.1053\/j.jrn.2019.03.083_bib61","first-page":"37","article-title":"The protective effect of valsartan and jinshuibao on diabetic nephropathy","volume":"21","author":"Lin","year":"2009","journal-title":"Tianjin Pharm"},{"key":"10.1053\/j.jrn.2019.03.083_bib62","first-page":"1452","article-title":"Effect of valsartan combined with Jinshuibao capsule in the treatment of type 2 diabetic nephropathy","volume":"24","author":"He","year":"2012","journal-title":"Med J Chin People's Health"},{"key":"10.1053\/j.jrn.2019.03.083_bib63","first-page":"18","article-title":"Clinical efficacy of valsartan combined with Jinshuibao in the treatment of diabetic nephropathy","volume":"11","author":"Lu","year":"2014","journal-title":"Diabetes New World"},{"key":"10.1053\/j.jrn.2019.03.083_bib64","first-page":"12","article-title":"Clinical observation of valsartan combined with Jinshuibao capsules for treating diabetic nephropathy","volume":"28","author":"Dai","year":"2016","journal-title":"J Henan Med Coll"},{"key":"10.1053\/j.jrn.2019.03.083_bib65","first-page":"60","article-title":"Valsartan plus Jinshuibao capsules for treating early diabetic\u00a0nephropathy with micro-inflammation","volume":"22","author":"Pu","year":"2013","journal-title":"Chin J Pharmacoepidemiol"},{"key":"10.1053\/j.jrn.2019.03.083_bib66","first-page":"72","article-title":"The clinical analysis of the treatment of early diabetic nephropathy by valsartan and Jinshuibao capsule","volume":"17","author":"Yan","year":"2017","journal-title":"World Latest Medicne Inf"},{"key":"10.1053\/j.jrn.2019.03.083_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2012.10.001","article-title":"Epidemiology of diabetic kidney disease","volume":"97","author":"Reutens","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1053\/j.jrn.2019.03.083_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ki.1997.2","article-title":"Understanding the nature of renal disease progression","volume":"51","author":"Remuzzi","year":"1997","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2019.03.083_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejphar.2006.06.047","article-title":"Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells","volume":"545","author":"Kim","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1053\/j.jrn.2019.03.083_bib70","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.fitote.2009.11.008","article-title":"Protection of chronic renal failure by a polysaccharide from Cordyceps sinensis","volume":"81","author":"Wang","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1053\/j.jrn.2019.03.083_bib71","first-page":"448","article-title":"Effect of Cordyceps sinensis on\u00a0expressions of HIF-1alpha and VEGF in the kidney of rats with diabetic nephropathy","volume":"38","author":"Yuan","year":"2013","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1053\/j.jrn.2019.03.083_bib72","first-page":"67","article-title":"Proapoptotic effect of angiotensin II on renal tubular epithelial cells and protective effect of Cordyceps sinensis","volume":"37","author":"Tu","year":"2012","journal-title":"J Cent South Univ(med Sci"},{"key":"10.1053\/j.jrn.2019.03.083_bib73","first-page":"294","article-title":"Pharmacodynamic differences in the literature research of Cordyceps sinensis and its fermented mycelium","volume":"26","author":"Yao","year":"2015","journal-title":"China Pharm"},{"key":"10.1053\/j.jrn.2019.03.083_bib74","first-page":"463","article-title":"Comparison and review on specifications of fermented Cordyceps sinensis products","volume":"43","author":"Yang","year":"2018","journal-title":"China J Chin Materia Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib75","first-page":"13","article-title":"Jinshuibao capsule was allowed to test production","volume":"10","author":"Deng","year":"1987","journal-title":"Chin Traditional Patent Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib76","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1142\/S0192415X1000838X","article-title":"Immunosuppressive effect of Cordyceps CS-4 on human monocyte-derived dendritic cells in\u00a0vitro","volume":"38","author":"Tang","year":"2010","journal-title":"Am J Chin Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib77","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/10755530260128005","article-title":"A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats","volume":"8","author":"Balon","year":"2002","journal-title":"J Altern Complement Med"},{"key":"10.1053\/j.jrn.2019.03.083_bib78","doi-asserted-by":"crossref","first-page":"9150807","DOI":"10.1155\/2018\/9150807","article-title":"Antioxidant and hypoglycemic effects of acidic-extractable polysaccharides from cordyceps militaris on Type 2 Diabetes Mice","volume":"2018","author":"Zhao","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1053\/j.jrn.2019.03.083_bib79","doi-asserted-by":"crossref","first-page":"1390418","DOI":"10.1155\/2018\/1390418","article-title":"Artificially cultivated Ophiocordyceps sinensis alleviates diabetic nephropathy and its podocyte injury via inhibiting P2X7R expression and NLRP3 inflammasome activation","volume":"2018","author":"Wang","year":"2018","journal-title":"J Diabetes Res"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122761930189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122761930189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:33:45Z","timestamp":1760942025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105122761930189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S105122761930189X"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2019.03.083","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Efficacy and Safety of Jinshuibao Combined With ACEI\/ARB in the Treatment of Diabetic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2019.03.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}